|
|
 |
|
Viewing report
|
|
|
|
India: Pharmaceutical and Biotechnology Opportunities
Pharmalicensing Ltd., April 2006, Pages: 111
- An overview of the Indian pharmaceutical industry
- Key players in the Indian pharmaceutical market
- An analysis of the regulatory environment and its implications for R&D
- Collaborative R&D opportunities in India
- Engagement models for licensing and purchasing innovation and for contracting research services
- Approaches to collaboration in NCE/NDDS, biopharma, drug discovery, biotechnology, bioinformatics, and clinical research
- Profiles of leading R&D companies—NCE/DDS, bioinformatics, biopharma, drug discovery, clinical research
- Profiles of life science research institutes
- Regional Government initiatives
India is an increasingly attractive destination for R&D activities in the pharmaceutical and biotechnology industry. Being an emerging market, companies face a number of unique hurdles before entering this lucrative region.
The report provides an overview of the Indian pharma and biotech market, and answers the following key questions:
- Who are the key players in the Indian pharmaceutical market?
- How has the Indian regulatory environment changed?
- What R&D collaborative opportunities are available?
- How can companies engage with India for collaboration?
- What are the leading R&D companies in India doing in collaborative R&D?
Readers will gain an analysis of the regulatory environment, insights into collaborative opportunities and detailed information on the key companies, clusters and government initiatives.
This report is a valuable resource for use by all those developing company strategy and direction in this key emerging market.
'India: Pharmaceutical and biotechnology opportunities' is based on the December 2004 report 'India: The emerging R&D collaborative opportunity'. The new report includes additional sections on the Indian Patents Act 2005, the Indian pharmaceutical policy, an overview of Department of Biotechnology initiatives, including details of biotechnology parks, and an all-new set of profiles on life science research institutes.
The profiles section of 'India: Pharmaceutical and biotechnology opportunities' contains updated profiles and contact details on key companies.
Reasons to Purchase
This report will provide the reader with an insight into the Indian pharmaceutical market and the emerging R&D collaborative opportunities on offer.
The report answers the following key questions about the Indian R&D collaborative opportunity:
- Who are the key players in the Indian pharmaceutical market?
- How has the Indian regulatory environment changed?
- What R&D collaborative opportunities are available?
- How to engage with Indian companies for collaboration?
- What are the leading R&D companies in India doing in collaborative R&D?
Who Should Buy the Report
This report is suitable to individuals responsible for and interested in:
- Board and executive management
- Business development
- Licensing/partnering
- Deal making
- Business strategy
- Marketing and promotion
- Distribution and manufacturing (including contract services)
- Contract R&D services
- Collaborative R&D opportunities
Customers who bought this item also bought
Biotechnology in India
Indian Biotechnology Market Outlook (2006)
Indian Pharmaceutical Industry
Indian Biotechnology Industry Report
Indian Pharmaceutical Industry: Strategies, Trends and Opportunities
Booming Biotech Market in India
Kick-Starting R&D in India: Challenges and Opportunities
Indian Pharmaceutical Industry: Issues and Opportunities
Indian Biotech Industry (2005)
Indian Pharmaceutical Industry
Key Trends In Drug-diagnostic Co-Development: Identifying Collaborative Opportunities and Navigating Regulatory Challenges
Opportunities for European Pharmaceutical and Biotechnology Companies in Indian and Chinese Markets
|
|
|
|
